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OsteoarthritisAbstract Experimental models of osteoarthritis (OA) have been widely developed in different ani-
mal species, because of the high incidence of osteoarthritis diseases in humans and animals. To date,
no ideal OA animal model has been reported. The present study compare different osteoarthritis
models to determine which one is suitable for inducing experimental equine OA. Fifteen donkeys
were divided into three equal groups (n= 5). The radio carpal joints of the right forelimb of 15
donkeys were injected with 25 mg monoiodoacetate (MIA) (group A), 50 mg allogenous cartilage
particles (ACP) (group B), or vehicle solution (group C) over a period of 70 days. Osteoarthritis
induction was evaluated weekly through lameness score, carpal circumference, joint ﬂexion angel,
synovial ﬂuid analysis (total protein and WBC count), and radiology. Animal were euthanized
and joints histopathology were performed at 70 days. Lameness score and joint circumference
was increased in both group A and B however joint ﬂexion angel was decreased compared to group
C (p< 0.05). Osteophytes were observed in MIA injected joints only accompanied with subchon-
dral bone sclerosis. Cartilage damage was observed grossly and histologically in Group A together
with synovial membrane ﬁbrosis. Group B had on cartilage damage grossly however histological
examination revealed some cartilage surface discontinuity with synovial membrane edema. Injec-
tion of monoiodoacetate in the donkey is a successful model to create the acute clinical signs of joint
disease as well as cartilage damage. However, allogenous cartilage particles injection need more
investigation to be applied.
ª 2014 Faculty ofVeterinaryMedicine,CairoUniversity. ProductionandhostingbyElsevierB.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
In the equine industry, lameness due to joint disease is the
most common cause of decreasing the performance in sport
horses. Several epidemiologic studies have found that lameness
due to joint disease is the most signiﬁcant factor responsible
for inability to race and loss of performance [1,2]. Therefore,
Iodoacetate and allogenous cartilage particles as models for arthritis induction in equine 143it is important to understand the pathogenesis and medications
available to the equine practitioner.
Equine osteoarthritis (OA) may be considered as a group of
disorders characterized by a common end stage: progressive
degeneration of the articular cartilage together with additional
changes in the bone and soft tissues of the joint. This degener-
ation of the articular cartilage is characterized by local splitting
and fragmentation (ﬁbrillation) of articular cartilage. Synovitis
and joint effusion are often associated with the disease, and,
clinically, the disease is characterized by pain and dysfunction
of the affected joint [3].
Animal models are standard research tools for studying the
pathogenesis, diagnosis and potential therapeutic intervention
of many different diseases. They provide us with information
to develop new drugs and moving it toward clinical use. The
different types of arthritis models have been previously
reviewed [4–7].
Common features of most experimentally-induced osteoar-
thritis models include the ability to deﬁne the type of joint dis-
ease, the severity of injury in addition to the time of onset and
progression and to relate these events to markers of disease
activity [4].
Arthritis-like changes have been induced in the horse by
Filipin [8], Amphotericin [9,10], turpentine oil [11], polyvinyl
alcohol foam [12], carrageenan [13], complete Freund’s adju-
vant [14]. Lipopolysaccharide [15], botulinum toxin [16],
forced exercise [17], osteochondral fragment-exercise mode
[18].
The monoiodoacetate (MIA) arthritis model has been used
in rats [19], chickens [20], guinea pigs [21], rabbits [22] and
horses [23–25] for assessment of the pathophysiologic process
as well as evaluation of the efﬁcacy of therapeutic substances
in a controlled environment.
Using cartilage particles to induce osteoarthritis was previ-
ously described in dog [26] and rabbit [27]. A combination of
intra-articular injection of cartilage particles, arthroscopic par-
tial thickness cartilage defect and exercise were used to create a
model of degenerative joint disease in the horse [28]. The fate
and effects of surgically implanted osteochondral fragments on
the middle carpal joint of horses subjected to exercise were
investigated [29].
The donkey is properly the closet animal to the horse,
making this species an alternative animal model for studying
equine diseases. Few papers reported using of donkey as a
model of equine OA [10,11].
In the present study, injections of allogenous cartilage par-
ticles (ACP) or monoiodoacetate (MIA) were used to create a
model of degenerative joint disease in the donkey. The clinical
examination, radiographic, macroscopic appearance, and light
microscopy were used to assess the effect of these treatments
on healthy cartilage compared to the vehicle control.
2. Material and methods
2.1. Donkeys
The experiment was approved by the Committee on Animal
Experimentation at the Kafrelsheikh University, Egypt.
The present study was performed using 15 healthy Egyptian
local breed male donkeys weighting from 150 to 200 kg. Ani-
mals were housed in indoor stalls and fed on a balanced rationof mixed grain with hay and unlimited water. All donkeys were
dewormed with ivermectin (200 mcg/kg; Eqvalan 1.87%
Merial Limited. USA).
Prior to inclusion in the study, lameness examination, body
condition, radiographs of carpal joints, range of motion of
carpal joints (angle of ﬂexion) and evidence of joint effusion
were assessed to ensure that all previous variables were within
normal limits (baseline measurement).
Donkeys were allowed to acclimatize for 2 weeks prior to
the study. During the acclimatization period, the donkeys
trained daily to familiarize them to the experimental
conditions (investigators, environment, handling, vein punc-
ture and various outcome measures).
2.2. Allogenous cartilage particle solution preparation (ACP)
One local breed donkey weight 150 kg was euthanized, and the
articular cartilage was removed from the shoulder, carpal, fet-
lock, pastern, hock and stiﬂe joints in a biosafety cabinet under
aseptic conditions. The pooled cartilage was powdered under
liquid nitrogen in a mortar, producing particles as small as
20 mm in diameter (able to pass easy through a 14-gauge nee-
dle). These particles were resuspended at a concentration of
50 mg/ml in a physiological saline solution contained amikacin
sulfate (50 mg/ml; Amikin 500 mg vial, Bristol Meyer Squiip,
Egypt).
2.3. Monoiodoacetate solution preparation (MIA)
MIA (Sodium monoiodoacetate 25 g, ICN, Biomedicals
GmBH Thuriger star be 15.Germany) were dissolved at a con-
centration of 25 mg/ml in a physiological saline solution con-
tained amikacin sulfate (25 mg/ml).
2.4. Study design
The 15 remaining donkeys were divided in to three groups of
ﬁve. Animals sedated with Xylazine Hcl (1 mg/kg; Rumpon
10%, Bayer animal health. Canada). The skin was aseptically
prepared for arthrocentesis of each right radiocarpal joint to
obtain synovial sample for baseline analysis. Group A received
25 mg (1 ml solution) of MIA, Group B received 50 mg (1 mL)
of ACP and Group C was received the suspended solution
(1 mL) without adding cartilage or MIA (Vehicle – Control
group) intra-articularly into the right radiocarpal joint using
a 14 G needle. These injections were repeated at 7, 14, 21,
28, 35, 42 and 56 days for group B and C however Group A
was received a single MIA injection (Fig. 1).
2.5. Outcome measures
2.5.1. Clinical examination
Clinical examinations of right forelimbs were performed
weekly from day 0 (baseline) throughout the study period.
2.5.2. Lameness score
Donkeys evaluated for lameness score on a scale 0–5 according
to American Association of Equine Practitioners (AAEP)
grading system (0: Lameness not perceptible with ﬂexion test,
1: lameness is difﬁcult to observe and is not consistently
Figure 1 Flowchart of the study protocol.
Figure 2 Illustration of cartilage collection sites from distal articular surface of the radius.
144 A. Elmesiry et al.apparent with ﬂexion test, 2: lameness apparent with ﬂexion
test, 3: lameness is consistently observable at a trot, 4: lameness
is obvious at a walk, 5: lameness produces minimal weight
bearing in motion) [30].2.5.3. Circumference of the carpal joint
Measurements obtained at the proximal aspect of the carpus
by using of a measurement tape (in cm), and with the aid of
the anatomical reference points (accessory, radial, ulnar and
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weekly; hair over the selected area was clipped on a regularly
scheduled basis [14].
2.5.4. Maximum carpal ﬂexion angel
Maximum carpal ﬂexion was measured weekly by slowly
ﬂexing the carpus until the donkey resisted. The angle was then
measured in degrees with Goniometer [14].
2.5.5. Synovial ﬂuid analysis
Synovial ﬂuid sample (1 mL) aseptically aspirated from each
joint before each injection. The conventional analysis of syno-
vial ﬂuid included assessment of total protein concentration,
white blood cell (WBC) count, and differential count. Total
protein concentrations and WBC were determined via
Double Beam UV Visible Spectrophotometer and use of an
automated cell counter, respectively [18].
2.5.6. Radiographic evaluation
Radiographic evaluation of both carpi was performed prior to
inclusion in the study (day 0), following the induction of osteo-
arthritis (day 7), and weekly to the end of the study (day 70).
The radiographs were taken in dorsopalmar view and a profes-
sor of radiology assessed images blindly without known of the
treatment group. The radiographic images were evaluated
categorically for bony proliferation at the joint capsule attach-
ment, subchondral bone sclerosis, and osteophyte formation
on a scale of 0–4 (0 represented normal, and 4 represented
severe change) [18].
2.5.7. Gross pathology of joint tissue
All donkeys were euthanized at day 70 by administration of
pentobarbitone sodium (100 mg/kg IV; Nembutal Sodium
5%. Lundbeck Inc. Deerﬁeld, IL 60015. USA) and tissue sam-
ples collected from joint capsule and articular cartilage
(Fig. 2). Carpal joints speciﬁcally examined for degree and
location of articular cartilage ﬁbrillation or erosion. A subjec-
tive grade (scale of 0–4) assigned for partial- and full-thickness
cartilage erosion as well as synovial membrane hemorrhage. A
total erosion score assigned, also with a scale of 0–4. For each
of the 2 variables, grade 0 represented no pathological change
and 4 represented a severe change [31].
2.5.8. Light microscopy
Specimens from the synovial membrane and joint capsule har-
vested and placed in neutral-buffered 10% formalin (NBF),
stained with H&E and examined microscopically. Samples
evaluated for cellular inﬁltration, synovial intimal hyperplasia,
subintimal edema, subintimal ﬁbrosis and subintimal vascular-
ity. Each variable was graded and reported as a numeric value
0–4 (0 = normal, 1 = slight change, 2 = mild change,
3 = moderate change, and 4 = severe change [31].
Full thickness articular cartilage samples of 5-mm2 diame-
ter were Obtained from each joint (Fig. 1 – shows squares).
Sampling sites chosen to represent an area of thick cartilage
(C1 & C2) and thin cartilage (C3 & C4) regions. Samples
placed in (NBF) for 7 days and then placed in 10% EDTA
for 21 days for decalciﬁcation then processed routinely to
parafﬁn wax for histological. Samples were sliced into 5-lmsections and stained with H&E, cartilage were graded on a
scale of 0–6 (Grade 0: smooth, grade 1: surface irregular, grade
2: surface discontinuous, grade 3: vertical ﬁssure, grade 4:
erosion, grade 5: denudation, grade 6: deformation) [32]
(Fig. 2).
2.6. Statistical analysis
Variables including lameness, carpal ﬂexion angel, carpal cir-
cumference, TP and TWBC analyzed using a repeated mea-
sures analysis of variance (ANOVA) model with SPSS
(Version 17: WinWrap Company release 2008). Any test with
a p value <0.05 was declared statistically signiﬁcant. When
individual comparisons were made, Bonferroni post hoc test
was used and p< 0.05 was considered signiﬁcant. The Krus-
kal–Wallis non-parametric ANOVA was used to evaluate sta-
tistical differences in gross pathological and histo-pathologic
scores. Values are reported as mean ± Standard deviation.3. Results
3.1. Clinical examination
3.1.1. Lameness score
Increasing in the lameness score begin at day 7 for group A
(2 ± 0), and at day 14 for group B (0.6 ± 0.49) and peak at
day 14 for group A (2.4 ± 0.49) and at day 21 for group B
(1.6 ± 0.49). At day 56, the lameness score was at lowest value
for group A (1 ± 0) and B (0.4 ± 0.49). Group C had no
lameness all over the study period (Fig. 3-A).
There was a signiﬁcant change between group A groups C
(p< 0.001) at each study day. However, group B was signiﬁ-
cantly different from group C at day 21, 28, 35 and 42. Group
A was signiﬁcantly difference from group B at days 7, 14 and
42 (p< 0.05).
3.1.2. Carpal circumference
Circumference in group A was strongly increased at day 7
(24.88 ± 0.55) then begin decline till the end of the study.
However, Group B was smoothly increased reached the peak
at day 35 (23.92 ± 0.48) then begin to decrease until the study
end. Group C was weakly increased but not signiﬁcantly chan-
ged (Fig. 3-B). Group A was signiﬁcantly difference from
group C at each study day (p< 0.05) and was signiﬁcantly dif-
ference from group B at day 7, 14, 21, 28, 56 and 70. However,
group B and C were not signiﬁcantly different from each other
(p> 0.05).3.1.3. Maximum carpal ﬂexion angel
The ﬂexion angel suddenly decreased at day 7 in-group A
(106 ± 3) then begin to decrease smoothly until the end of
the study. Group B decreased smoothly until reach the peak
at day 35 (141 ± 2) then begin to decrease to the end of the
study. Group C had a constant ﬂexion angle throughout the
study period (Fig. 3-C). Group A was signiﬁcantly difference
from group B and C on each study day (p< 0.05). However,
group B was signiﬁcantly different from group C from day 21
until day 42.
Figure 3 (A) Main lameness score over the study period. (B)
Main Carpal Circumference over the study period. (C) Main
carpal ﬂexion angle over the study period.
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Synovial WBC count was increased at day 7 in all groups.
Group A reached its peak at day 7 (874 ± 72), group B at
day 35 (620 ± 74) and group C at day 42 (360 ± 81).
Group A was signiﬁcantly difference from group B and C
on each study day (p< 0.05). However, group B was signiﬁ-
cantly different from group C on study day 14, 21, 28, and 35.
Total protein also increased in Group A, Group B and
Group C after the ﬁrst injection throughout the study. Group
A was signiﬁcantly difference from group B and C (p< 0.05)
but Group B and C were not signiﬁcant difference from each
other.3.1.5. Radiographic analysis
At day 70 group B and C treated joints had no radiographic
changes while Group A treated joints of all donkeys had grade
4 radiographic score with narrowing of joint space and second-
ary features as osteophytes formation, and subchondral bone
sclerosis (Fig. 4). There was a signiﬁcant (p< 0.0001)
difference between group A and the other groups.
3.1.6. Gross pathology
Group A had partial and full thickness erosion (Mean
2.67 ± 0.47) with a signiﬁcant difference from group B & C
(p= 0.023). However, group B & C had no gross ﬁbrillation
or ﬁssuring (Mean 0 ± 0) and were thus not different from
each other (Fig. 5). The synovial membrane hemorrhage had
signiﬁcantly difference between the three groups (p= 0.047).
Group A was signiﬁcantly deference from group B
(p= 0.034) and group C (p= 0.001). Group B & C also were
not signiﬁcantly deference from each other (p= 0.114).
3.1.7. Light microscopy of synovial membrane
Induction of osteoarthritis did not result in signiﬁcant change
in synovial membrane intimal hyperplasia or subintimal edema
(p= 0.139). Group A&B had slight changes (1 ± 0).
Synovial membrane cellular inﬁltration was increased in
Group A (3.33 ± 0.47), and group B (1 ± 0). Group A was
signiﬁcantly different from group B (p= 0.034). Group A
characterized by large cartilage particles embedded inside the
subintimal layer surrounded by a sever zone of cellular inﬁltra-
tion (Fig. 6).
Synovial membrane vascularity was increased in Group A
(2.67 ± 0.47) and group B (0.66 ± 0.47). Group A was signif-
icantly different from group B (p= 0.034).
Synovial membrane ﬁbrosis was increased in Group A
(2.67 ± 0.47). Group A was again signiﬁcantly different from
Group B & C (p= 0.034). However Group B & C were not
different (p= 0.099).
3.1.8. Light microscopy of articular cartilage
Histologic evaluation of sample C1 via H&E revealed a signif-
icant increase in OA score for Group A from Group B
(p= 0.043) and Group C (p= 0.034). There was a signiﬁcant
difference between Group B and Group C (p= 0.034). C1 &
C2 histologic score revealed more damage than C3 & C4
although this difference was not signiﬁcant (p= 0.518). Lesion
on In Group A (C1: 3.67 ± 0.47 & C3: 2.67 ± 0.47), however,
vertical ﬁssures (matrix vertical ﬁssures into mid zone) and ero-
sion (superﬁcial layer and mid zone lost their matrix) were the
most common (Fig. 7A). Group B (C1: 1.67 ± 0.47 & C3:
0.67 ± 0.47), suffered from matrix discontinuity at superﬁcial
zone, disorientation of chondron columns and cell prolifera-
tion (clusters) (Fig. 7B).Group C revealed normal architecture
and, appropriate orientation of the Cells (Fig. 7C).
4. Discussion
Experimental models of osteoarthritis (OA) have been widely
developed in different animal species Because of the high
incidence of osteoarthritis diseases in humans and animals,
however none of the existing models perfectly resemble the
natural disease [6].
Figure 4 Representative images of the dorsopalmar radiographs of the carpal joint of Group A, B, & C. white arrows refer to
osteophytes, black arrows refer to thinning of articular cartilage however, and the black asterisks refer to subchondral bone sclerosis.
Figure 5 Representative images of the gross morphology of the distal articular surface of the radius of Group A, B, & C. Black arrows
refer to full thickness cartilage erosion however, arrows head refer to partial thickness cartilage erosion.
Figure 6 Representative images of the light microscopy image of the synovial membrane of the three groups A, B and C. Black arrows
refer to cartilage fragments. H & E stain 10·.
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cartilage particles or monoiodoacetate effectively resulted in
clinical, histologic, and biochemical changes indicative of
osteoarthritis. Lesions are vary from mild osteoarthritis with
superﬁcial cartilage ﬁbrillation to moderate osteoarthritis with
cartilage erosion. During this study, no adverse events were
recorded with any of the treatment doses and a mild degree
of lameness was induced.
MIA act by inhibiting the glyceraldehyde-3-phosphate
dehydrogenase activity in the chondrocytes (an inhibitor of gly-
colysis) promotes loss of articular cartilage similar to that noted
in human OA [19]. In the absence of an effective treatment, the
model will induce pathological detectable features of OA [25].
The mechanisms of action of ACP to create cartilage ero-
sion is controversial, but probably occurs by two mechanisms.
First, cartilage particles may initially act as abrasives to liber-
ate more ‘wear particles’ which are engulfed by the synovialmembrane [33,34] causing metaplastic changes in the mem-
brane, abnormal synovial ﬂuid constituents and synovitis. Sec-
ondly, cartilage particles may also stimulate synovial cells via
immune system to produce cellular mediators and/or protein-
ases which result in depletion of cartilage matrix, either
directly or by acting on the chondrocytes [35].
To study osteoarthritis in horses we should use an animal
model phylogenetically, biomechanically and biochemically
close as is possible in order to most accurately reﬂect patho-
logic process in the target species [7]. Thus for horse a donkey
model is likely to be superior to a dog, rabbit or mouse model.
Donkey has many beneﬁts that give him the opportunity to
become a good alternative for the horse including low animal
price, feed stuff and animal housing, in addition to large joint
sample for histopathology.
In the horse, complete surgical transection of the cranial
cruciate ligament in horses has not resulted in progressive
Figure 7 Reprehensive images of the light microscopy image of the articular cartilage (C1) of the three groups A, B and C. H & E stain
10·.
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hol foam [12] induces transient lameness, but only for a short
period. Application of Escherichia coli lipopolysaccharide
(LPS) [15], Amphotericin [9] or the polyene antibiotic ﬁlipin
[8], Freund’s complete adjuvant [14] are well-described models,
but use of either can result in severe, non-weight-bearing lame-
ness, induce irreversible osteophytosis and articular lesions. In
addition, all these agents can result in substantial increase in
the circumference of the joint, compared with that of the con-
trol joint, owing to severe inﬂammatory response in the periar-
ticular tissues.
In the osteochondral fragment models, the animals are sub-
jected to very invasive surgery with postoperative antibiotics
and non-steroidal anti-inﬂammatories that may affect the
function of the body system. In addition, induction of the
chondral defects lack the natural sequence of the disease
process.
Single MIA dose used upon previous work in horse where
0.16 mg/kg was used [25]. ACP dose was made upon previous
work with rabbit where 1 mg/kg was used [27]. Repeated injec-
tion of ACP is needed to accelerate a natural degenerative pro-
cess that normally takes years to develop.
Lameness is often a feature of natural or experimentally
induced OA. In some cases, lameness may be severe that limits
usefulness of a model [8]. Despite the fact that articular carti-
lage degeneration was induced in our study, lameness was a
major feature of MIA group in contrast to the ACP groups.
In the ACP group, carpal circumference and joint ﬂexion
angel changes were changed smoothly in contrast toMIA group
in which changes are strongly specially after the ﬁrst injection.
Rapid response to the MIA injection resemble the acute trau-
matic joint disease with local pain on palpation. This giving
the MIA the priority to be a good model for acute synovitis.
Increase synovial ﬂuid WBC and TP in MIA at day 7 is
indicative for the acute synovitis and conﬁrm the evidence of
clinical signs of lameness and pain. However in ACP group,
response is delayed to day 14 without increase in TP which
may be due to low cartilage dose to initiate inﬂammatory
response.Periarticular osteophyte and narrowed joint spaces were a
signiﬁcant feature in MIA injected joints. This is in opposite
to other studies using MIA joint disease models [23,24] how-
ever, absence of radiographic changes with ACP was in con-
trast to other studies by Evan [27] in which presence of
osteophytes in the knee joints of one group of rabbits after
4 months of cessation of injections.
Gross cartilage degeneration is conﬁrming the narrowing
on the joint space on the radiographic ﬁlm on MIA group.
Additionally the synovial membrane hemorrhage is indicative
for the inﬂammatory process which happen on the synovial
membrane.
In our study superﬁcial cartilage ﬁbrillation were observed
on the ACP group, this conﬁrm the previous study in the horse
where the lesions were limited to wear lines and areas of carti-
lage thinning together with capsular ﬁbrosis and synovial
membrane hyperplasia [28]. The difference in synovial mem-
brane lesion may be due to prolongation of the study period
(6 months). While in other species synovitis, stiffness, and mar-
ginal exostoses without damage to the articular surfaces were
detected grossly or microscopically [26,27]. On the MIA group
vertical ﬁssures and erosion were observed, these in agreement
with the previous studies on the horse [23,24]. There was some
variability in the degree of articular cartilage changes within
the same group; this may be due to imperfect correlation
between body weight and carpal diameter.
Mild synovial membrane lesion in ACP group come in con-
trast with other studies conducted on the cartilage particle injec-
tion reported synovial ﬁbrosis [26] with small cartilage particles
engulfed inside the synovial subintimal layer [27,28]. However,
other studies also reported synovial intimal hyperplasia [28]. On
MIA group, presence of large cartilage particles embedded
inside the subintimal layer is conﬁrming erosion and deteriora-
tion of the cartilage surface together with leukocytic inﬁltration.
5. Recommendations
At dosage of 50 mg/joint MIA, Acute synovitis was reported at
day 7 in addition to moderate degrees of articular cartilage
Iodoacetate and allogenous cartilage particles as models for arthritis induction in equine 149change at day 70. This degree of articular cartilage change gen-
erally resulted in cartilage erosion extended to deep layer and
focal to diffuse gross pathologic changes in articular cartilage.
On the basis of these variables, thismodelmay be useful for eval-
uating anti-inﬂammatory drugs at the early stages (day 7) and
also the disease modifying OA drugs at the late stages (day 70).
6. Conclusion
MIA model was successful in producing acute synovitis and
joint pain in addition to degenerative joint disease. This model
could be useful to those studying the pathophysiology of joint
disease and may be an ideal method to test the efﬁcacy of new
drugs intended for the treatment of joint disease. ACP model
need more investigation and studying of the appropriate
ACP dose and the number of injections.
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